1. Home
  2. IQV vs DXCM Comparison

IQV vs DXCM Comparison

Compare IQV & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$183.57

Market Cap

28.6B

Sector

Health Care

ML Signal

N/A

Logo DexCom Inc.

DXCM

DexCom Inc.

N/A

Current Price

$76.69

Market Cap

28.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IQV
DXCM
Founded
1982
1999
Country
United States
United States
Employees
93000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6B
28.1B
IPO Year
2013
2005

Fundamental Metrics

Financial Performance
Metric
IQV
DXCM
Price
$183.57
$76.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
21
Target Price
$227.13
$85.33
AVG Volume (30 Days)
1.5M
6.4M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
4.67
47.18
EPS
1.61
0.51
Revenue
$9,739,000,000.00
N/A
Revenue This Year
$6.77
$14.46
Revenue Next Year
$5.89
$12.31
P/E Ratio
$113.94
$142.86
Revenue Growth
41.60
N/A
52 Week Low
$153.23
$54.11
52 Week High
$247.05
$89.07

Technical Indicators

Market Signals
Indicator
IQV
DXCM
Relative Strength Index (RSI) 58.16 71.97
Support Level $176.99 $62.86
Resistance Level $191.78 $81.64
Average True Range (ATR) 6.97 2.95
MACD 1.22 0.53
Stochastic Oscillator 78.91 92.96

Price Performance

Historical Comparison
IQV
DXCM

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

About DXCM DexCom Inc.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

Share on Social Networks: